Skip to main content
Treating multi drug resistant TB and HIV/AIDS in Manipur, India

Access to medicines

War in Gaza:: find out how we're responding
Learn more
Unaffordable, unavailable, not adapted - people around the world face these challenges in accessing lifesaving medicines.

During the 1990s, MSF teams made a bitter observation: we were failing to treat some of our patients suffering from infectious diseases, while in developed countries, remarkable progress was being made in the field of health. Two decades on, medicines in developing countries are still either too expensive, aren't suitable to be used in many of the contexts in which we work (for example, in hot, humid conditions or where there's a lack of electricity), or simply don't exist for the diseases we need to treat.

In 1999, we launched the Campaign for Access to Essential Medicines, now known as the Access Campaign. Its mission focuses on three areas: overcoming barriers to access to essential medicines, stimulating research and development for neglected diseases, promoting health exceptions to global trade agreements.

In 2003, MSF joined several research institutes, including the Institut Pasteur, to create the Drugs for Neglected Diseases initiative (DNDi), a non-profit research and development organisation engaged in research and development of new treatments for neglected diseases.


MSF Access Campaign
medicine for the treatment of drug resistant tuberculosis

MSF reveals cost of landmark TB clinical trial in push for drug-development cost transparency

Press Release 25 Apr 2024
Amaka Joseph, 35
Access to Healthcare

Urgent measures needed to address gaps in Universal Health Coverage targets

Report 13 Sep 2023
Mozambique: The challenge of a safe pregnancy and childbirth in Cabo Delgado
Access to Healthcare

Universal Health Coverage targets leave behind the most vulnerable

Interview 13 Sep 2023
Anam, 17-years-old DR-TB patient

Johnson & Johnson and Cepheid must pledge access to lifesaving TB medicines and tests

Press Release 12 Sep 2023
MSF collaborates with local NGOs to support vulnerable groups during the Omicron wave in Hong Kong
Epidemics and pandemics

MSF statement on WHO negotiating body meeting on pandemic prevention, preparedness and response

Speech 28 Feb 2023
Access to medicines

Lack of a real IP waiver on COVID-19 tools is a disappointing failure for people

Statement 17 Jun 2022
Dilaram, 33, a former TB-PRACTECAL clinical trial patient in Nukus

WHO approves MSF MDR-TB trial regimen, but prices must come down

Press Release 4 May 2022
Northeast Syria COVID-19 | Raqqa Hospital Medical Care
Access to medicines

“Broken” humanitarian COVID-19 vaccine system delays vaccinations

Press Release 27 Apr 2022
Access to medicines

Access to medicines project survey results

Report 29 Sep 2021
Up Next
30 August 2019